Search Within

Sean McCarthy Devlin

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (71)
  2. Journal Article (54)
  3. Research Letter (3)
  4. Correspondence (1)
Groups
  1. Biostatistics Service (129)
  2. Epidemiology and Biostatistics (129)
  3. Sloan Kettering Institute Postdocs (129)
  4. Center for Hematologic Malignancies (125)
  5. Department of Medicine (124)
  6. Hematologic Malignancies, Division of (124)

More Groups

People
  1. Sergio Giralt (72)
  2. Gunjan Shah (61)
  3. Michael Scordo (58)
  4. Miguel-Angel Perales (54)
  5. Parastoo Dahi (42)
  6. Malin Hultcrantz (32)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (22)
  4. 2022 (13)
  5. 2021 (14)
  6. 2020 (15)

More Years

Publications
  1. Blood (48)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Blood Advances (8)
  4. Clinical Lymphoma, Myeloma and Leukemia (5)
  5. Journal of Clinical Oncology (5)
  6. Transplantation and Cellular Therapy (4)

More Publications

Publishers
  1. American Society of Hematology (56)
  2. Elsevier Inc. (19)
  3. Nature Publishing Group (12)
  4. American Association for Cancer Research (5)
  5. American Society of Clinical Oncology (5)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (129)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lactose drives Enterococcus expansion to promote graft-versus-host disease
    Journal Article

    Stein-Thoeringer, C. K.; Nichols, K. B.; Lazrak, A.; Docampo, M. D.; Slingerland, A. E.; Slingerland, J. B.; Clurman, A. G.; Armijo, G.; Gomes, A. L. C.; Shono, Y.; more...
    Science (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CD97 is a critical regulator of acute myeloid leukemia stem cell function
    Journal Article

    Martin, G. H.; Roy, N.; Chakraborty, S.; Desrichard, A.; Chung, S. S.; Woolthuis, C. M.; Hu, W.; Berezniuk, I.; Garrett-Bakelman, F. E.; Hamann, J.; more...
    Journal of Experimental Medicine (2019)

    Fulltext@MSK | Save
  • CD36 is a leukemia stem cell chemoresistance gene and confers an adverse prognosis in acute myeloid leukemia
    Meeting Abstract

    Gonzalez, M. D.; Habeeb, O.; Stranahan, A.; Hu, W.; Devlin, S.; Liu, C.; Arbini, A.; Park, C.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • CD36 is a leukemia stem cell chemoresistance gene and confers an adverse prognosis in acute myeloid leukemia
    Meeting Abstract

    del Rey Gonzalez, M.; Habeeb, O.; Stranahan, A.; Hu, W.; Devlin, S.; Liu, C.; Arbini, A.; Park, C.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
    Journal Article

    Rustad, E. H.; Hultcrantz, M.; Yellapantula, V. D.; Akhlaghi, T.; Ho, C.; Arcila, M. E.; Roshal, M.; Patel, A.; Chen, D.; Devlin, S. M.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save